The invention relates to analytical approaches towards determining drug bioavailability and the development of topical formulations for pharmaceutical products. The invention relates to a non-invasive method for localisation and/or quantification of 19F-containing compounds via 19F magnetic resonance (MR) imaging or spectroscopy, after topical administration of said compound to a subject. The invention also relates to an MR-system for conducting said method.